2021-07-05 Seo Sang-ho, Chongqing Trade Center, China
– Promoting remediation of medical resource imbalance through medical data construction and convergence with smart infrastructure –
– Expansion of investment in medical big data industry based on AI technology and big data –
Recently, in China, to solve the problem of imbalance in medical resources, smart treatment that is fused with the construction of big data in the medical industry and 5G infrastructure is being promoted in various ways. It is accumulating data generated from medical fields, R&D and bio industries, and converges them into smart infrastructure. Through the establishment of such a smart medical system, it is bringing about changes such as resolving medical imbalances, improving R&D speed, and driving growth of the healthcare industry. In China, there is a regional imbalance in medical resources. In China, hospitals are divided into 3rd grade, 2nd grade, and 1st grade according to the manpower and size of hospitals. Most of the third-class hospitals, the highest grade, are concentrated in metropolitan areas.
According to recent data from the Chenjan Industrial Research Institute, 'There is an imbalance in the distribution of medical resources in China. While improving the supply level of hospitals, we are trying to improve hospital operation efficiency and management capabilities through the introduction of digitalized medical management solutions for public hospitals.' In addition, the growth potential of medical big data solutions through the accumulation of medical data in China, such as accelerating the R&D process and marketing paradigm shift by using big data in the life science R&D field, is very large.
The main sources of medical data that form the basis of China's medical big data include data generated in the treatment process of patients, clinical medical research and laboratory data, data generated by pharmaceutical companies and bio-life science, and data accumulated from internet platforms or APPs. etc.
Medical Big Data Policy Trends
According to data from mhealthchina.org, the level of medical data conversion of medical-related companies (including hospitals) is only about 7%, falling behind the average of 15% in other industries. In recent years, the Chinese government has announced several policies to build medical big data, and the scale of investment related to medical big data continues to expand in the industry.
China Medical Big Data Related Policy
Source: Organized by KOTRA Chongqing Trade Center, etc. by the China National Sanitation Plan and Growth Committee
Investment in China's medical big data industry
(Unit: billion yuan)
Source: Chenjan Industrial Research Institute
China's medical dataization investment in 2019 composition ratio by sector
Source: Chenjan Industrial Research Institute
According to the Equal Ocean platform's analysis report on the healthcare industry released in December 2020, China's healthcare market has changed significantly due to the impact of COVID-1919. Digital technologies such as the Internet and digital intelligence have already brought about many changes to various industries, and the "digital wind" triggered by this has brought about changes even to the most stubborn and conservative healthcare industry. With the explosive growth of new technologies such as AI and big data, China's healthcare digital enterprises are also facing a changing environment. In this digitalization of the healthcare market, China's healthcare big data construction, utilization, and solution market are also important axes. As China's healthcare big data construction accelerates, the types and scale of healthcare big data are also rapidly increasing, and the healthcare big data solution market is also growing rapidly. According to a recent report released by the Anyong Industrial Research Institute, China's healthcare big data solution market was worth 2019 billion yuan in 105 and is expected to reach 2024 billion yuan in 577.
China Medical Big Data Solutions Market Size and Forecast
(Unit: billion yuan)
Source: Anyung Industrial Research Institute
implication
According to local media, the development of medical data in China progressed rapidly during the COVID-1919 epidemic prevention and control process last year. During the COVID-1919 epidemic prevention and control period, the demand for non-face-to-face treatment increased rapidly, and in order to meet this demand, online treatment and digital treatment were implemented, and at the same time, the relevant data generated in this process began to be digitized and accumulated. According to an official from the Wuhan University Health and Medical Big Data Research Institute, during the implementation of COVID-1919 epidemic prevention and control policies, the COVID-2020 personal quarantine QR code (Health Code 建康吗) was used in Hangzhou in February 2, and it was used throughout Hangzhou City one week after the health code was launched, and it was used in all regions of China within one month. The health code is a representative case of big data application in epidemic prevention and control management, and it is expected that its application fields will rapidly expand through various channels in the future. An official from the Guiyang City Big Data Expo, whom we met at the China Big Data Expo held in Guiyang, Guizhou Province on May 1919, said, “China’s big data industry is now entering a new stage of development. Big data in various fields is developing through the convergence of various economic entities, and in particular, it is expected that the convergence of medical big data, artificial intelligence, and smart infrastructure will be widely utilized in resolving medical imbalances and in medical and bio research.” Regarding the trend of developing the medical industry utilizing big data in inland western China, which has relatively insufficient medical resources, related Korean companies also need to pay attention to the healthcare and medical big data-related industries in inland western China.
Source: Comprehensive data from China Chenzan Industrial Research Institute (former 瞻产业研究院), mhealthchina.org, Anyong Industrial Research Institute, Zhiyan Consulting (智研咨询), KOTRA Chongqing Trade Center